Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review

• Main Authors: José Adão Carvalho Nascimento Junior (Author), Anamaria Mendonça Santos (Author), Ana Maria Santos Oliveira (Author), Adriana Gibara Guimarães (Author), Lucindo José Quintans-Júnior (Author), Henrique Douglas Melo Coutinho (Author), Natália Martins (Author), Lysandro Pinto Borges (Author), Mairim Russo Serafini (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 2296-2565; 10.3389/fpubh.2020.563095
• Keywords: coronavirus (2019-nCoV); COVID-19 (condition); MERS (middle east respiratory syndrome); SARS; ELISA (enzyme linked immuno sorbent assay); isothermal amplification; Public aspects of medicine; RA1-1270
• Source: Frontiers in Public Health, Vol 8 (2020)

The emergence of a new coronavirus (SARS-CoV-2) outbreak represents a challenge for the diagnostic laboratories responsible for developing test kits to identify those infected with SARS-CoV-2. Methods with rapid and accurate detection are essential to control the sources of infection, to prevent the spread of the disease and to assist decision-making by public health managers. Currently, there is a wide variety of tests available with different detection methodologies, levels of specificity and sensitivity, detection time, and with an extensive range of prices. This review therefore aimed to conduct a patent search in relation to tests for the detection of SARS-CoV, MERS-CoV, and SARS-CoV-2. The greatest number of patents identified in the search were registered between 2003 and 2011, being mainly deposited by China, the Republic of Korea, and the United States. Most of the patents used the existing RT-PCR, ELISA, and isothermal amplification methods to develop simple, sensitive, precise, easy to use, low-cost tests that reduced false-negative or false-positive results. The findings of this patent search show that an increasing number of materials and diagnostic tests for the coronavirus are being produced to identify infected individuals and combat the growth of the current pandemic; however, there is still a question in relation to the reliability of the results of these tests.